Senior scientist, MRC Clinical Trials Unit at UCL, UCL

Andrew Nunn joined the MRC’s Tuberculosis & Chest Diseases Unit as a statistician in 1966. During the next 20 years he was directly involved in the design, conduct and analysis of the programme of trials conducted under the leadership of Professors Wallace Fox and Denny Mitchison in East Africa, Hong Kong and Singapore which led to the worldwide adoption of short course chemotherapy for tuberculosis.

Following the closure of that unit he joined the MRC’s Uganda AIDS Programme which researched the dynamics of the HIV epidemic in a rural African environment. On his return to the UK he became head of the Division Without Portfolio within the newly formed MRC Clinical Trials Unit with responsibility for developing trials in neglected areas. Currently, he is co-chief investigator on STREAM, the first Phase III trial in multidrug-resistant TB.

Experience

  • 2000–present
    Senior Scientist, MRC Clinical Trials Unit

Education

  • 1966 
    University of Sussex, MSc Statistics

Honours

International Union Against TB & Lung Disease medal 2018